Dr. Aziza Glass is a Doctor of Veterinary Medicine graduate from Cornell University. She was born in Houston, Texas, and nurtured her love of animals by watching television documentaries and ...
Merck’s (MRK) animal health unit announced that the U.S. FDA approved a label expansion for its once-yearly parasiticide treatment Bravecto Quantum to treat two additional tick species in dogs.
Expanded label for once-yearly parasiticide treatment for dogs now includes Haemaphysalis longicornis (Asian longhorned tick) ...
Officials with the FDA have approved a label expansion for fluralaner for extended-release injectable suspension (Bravecto ...
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect dogs for up to 12 ...
Dogs across the U.S. could soon get longer-lasting protection against pesky parasites thanks to a new treatment approved by federal regulators Thursday. NOTE: This video is from a previous report. The ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced ...
The BBB National Programs' Advertising Division has recommended that Merck Animal Health revise Bravecto Quantum marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results